Molecular Profiles, a leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors worldwide, has been awarded a QueenÆs Award for Enterprise in the Continuous Innovation and Development category.
The Queen’s Award for Enterprise recognises Molecular Profiles’ contract research services, which encompass the company’s knowledge and skills in advanced analytical techniques. Molecular Profiles’ scientists continually develop the company’s range of applications, based on advanced surface analysis and nanotechnology, which provide an insight into the properties of pharmaceutical and biomedical products.
“We are extremely honoured to be awarded this prestigious accolade,” comments Dr Nikin Patel, Molecular Profiles’ chief executive officer. “Our services and technology are extremely innovative but it is our scientists who develop the solutions that solve our customers’ challenges. This award recognises their expertise and commitment in making Molecular Profiles a cutting-edge global contract research company.”
Professor Martyn Davies, chairman and a founder of Molecular Profiles, comments: “Our company was founded on innovation and I am proud to say that this ethos has remained as the company has grown successfully over the last 10 years.
I congratulate the whole team at Molecular Profiles for its amazing efforts, which have been recognised through this award.”